UK MDx Shop Biofortuna Raises $1.6M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK molecular diagnostics shop Biofortuna confirmed that it has raised £1.1 million ($1.6 million) in a Series A round to launch the company's first diagnostic genotyping product.

In addition to supporting the product pipeline, the funds raised will be used to hire additional sales and marketing staff, Mike Bunce, CEO and chief scientific officer of Liverpool-based Biofortuna, told GenomeWeb Daily News in an e-mail.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.